BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23246719)

  • 21. High-density lipoproteins: marker of cardiovascular risk and therapeutic target.
    Toth PP; Davidson MH
    J Clin Lipidol; 2010; 4(5):359-64. PubMed ID: 21122679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Can cardiovascular events be prevented by raising HDL cholesterol?].
    Langslet G; Reikvam A
    Tidsskr Nor Laegeforen; 2008 Jun; 128(13):1519-23. PubMed ID: 18587459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
    Malle E; Marsche G; Panzenboeck U; Sattler W
    Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cholesterol bound to high density lipoproteins: critical review of the methods of analysis and personal data].
    Orso Giacone G
    Ann Osp Maria Vittoria Torino; 1982; 24(7-12):286-306. PubMed ID: 7137764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is raising HDL a futile strategy for atheroprotection?
    Joy T; Hegele RA
    Nat Rev Drug Discov; 2008 Feb; 7(2):143-55. PubMed ID: 18239670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of oral contraceptives on lipid metabolism.
    Krauss RM
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.
    van Eijk IC; de Vries MK; Levels JH; Peters MJ; Huizer EE; Dijkmans BA; van der Horst-Bruinsma IE; Hazenberg BP; van de Stadt RJ; Wolbink GJ; Nurmohamed MT
    Arthritis Rheum; 2009 May; 60(5):1324-30. PubMed ID: 19404933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-density lipoprotein and inflammation in cardiovascular disease.
    Connelly MA; Shalaurova I; Otvos JD
    Transl Res; 2016 Jul; 173():7-18. PubMed ID: 26850902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The versatility of HDL: a crucial anti-inflammatory regulator.
    Säemann MD; Poglitsch M; Kopecky C; Haidinger M; Hörl WH; Weichhart T
    Eur J Clin Invest; 2010 Dec; 40(12):1131-43. PubMed ID: 20695882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardioprotective functions of HDLs.
    Rye KA; Barter PJ
    J Lipid Res; 2014 Feb; 55(2):168-79. PubMed ID: 23812558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function.
    Marsche G; Holzer M; Wolf P
    Exp Dermatol; 2014 Oct; 23(10):701-4. PubMed ID: 24980461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute high-density lipoprotein therapies.
    Duong M; Di Bartolo BA; Nicholls SJ
    Curr Opin Lipidol; 2015 Dec; 26(6):521-5. PubMed ID: 26382551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HDL metabolism].
    Genschel J; Schmidt HH
    Z Gastroenterol; 2001 Apr; 39(4):321-7. PubMed ID: 11367981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.
    Kappelle PJ; van Tol A; Wolffenbuttel BH; Dullaart RP
    Cardiovasc Ther; 2011 Dec; 29(6):e89-99. PubMed ID: 20645987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-density lipoproteins: multifunctional vanguards of the cardiovascular system.
    Marcil M; O'Connell B; Krimbou L; Genest J
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):417-30. PubMed ID: 15151487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-density lipoprotein functionality in coronary artery disease.
    Kosmas CE; Christodoulidis G; Cheng JW; Vittorio TJ; Lerakis S
    Am J Med Sci; 2014 Jun; 347(6):504-8. PubMed ID: 24603157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human genetics of HDL: Insight into particle metabolism and function.
    Brunham LR; Hayden MR
    Prog Lipid Res; 2015 Apr; 58():14-25. PubMed ID: 25601427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of HDL genes: transcriptional, posttranscriptional, and posttranslational.
    Kardassis D; Gafencu A; Zannis VI; Davalos A
    Handb Exp Pharmacol; 2015; 224():113-79. PubMed ID: 25522987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.